Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Nov 2023
Most cancers become lethal because they remain silent until they are too advanced to be treated, at which point they show no symptoms. Specifically, gastric and ovarian cancers.
Read Full News8 Pulmonology Headlines You Missed in September 2026
The Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 extends federal support for ALS research and expanded access to investigational therapies, with additional provisions addressing clinical trial oversight and regulatory planning.
The professor of neurology at the University of Lyon and 2026 Rachel Horne Prize Winner discussed pregnancy counseling, therapeutic inertia, and overlooked women's health issues in multiple sclerosis.
Jennifer Soung, MD, and Mona Shahriari, MD, discuss diagnosing psoriasis in diverse skin tones and why severity scores overlook dyspigmentation.
AMETHYST: Litifilimab Sustains CLE Gains at 52 Weeks, With Victoria Werth, MD
EADV Congress 2026: Day 3 Recap—5 Headlines to Know
Upadacitinib Tops Nemolizumab on Skin, Itch Targets in Indirect Analysis
1.
Study offers clearer picture of childhood brain tumor survival
2.
PSMA PET Beats MRI in Prostate Cancer Staging Study
3.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
Snus Linked to Gingival Damage, Raising Safety Questions
1.
Oncology Treatment: Innovations, Education, and Clinical Practice Insights
2.
The Future of Hematology: Innovations Every Doctor Should Know
3.
Essential Applications in Oncology in Daily Practice
4.
Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies
5.
Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
Navigating the Complexities of Ph Negative ALL - Part XV
3.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
4.
Updates on Standard V/S High Risk Myeloma Treatment
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge